Abstract
Background: Cutaneous melanoma is an uncommon malignancy in children and for this reason, there is little information available regarding the timing and patterns of recurrence in children with this disease. This study reviews the experience at a single institution (Duke University Melanoma Clinic) in treating children with malignant melanoma.
Methods: Eighty-five patients ≤18 years of age with malignant melanoma have been treated. All but three patients were over the age of 10; 73% of them were >14. As for adults, treatment consisted of wide local excision of all primary lesions with primary closure or split-thickness skin graft, as needed. In addition, 22 patients underwent dissection of regional lymph nodes. Patients whose tumors had aggressive pathologic characteristics were treated with an adjuvant immunotherapy protocol. Patients with recurrence at distant sites were offered combination chemotherapy.
Results: Patients and pathologic characteristics of sex, race, primary site, histologic type, tumor thickness, and Clark level were similar to those observed in adults. Actuarial survival rates (79% versus 77% at 5 years) of the pediatric and adult Stage I melanoma patients were also not significantly different. Children had a greater incidence of recurrence after initial treatment, although recurrence tended to happen after a longer disease-free interval than for adults. Half of the 79 children who were first seen with Stage I disease have suffered a relapse, but more than one-third were disease free for ≥5 years after initial treatment. Of the 18 patients who were disease free for ≥7 years, 12 (67%) ultimately had recurrent disease, including five patients who had recurrences >13 years after initial diagnosis.
Conclusions: The early age at which malignant melanoma may occur and the significant potential for very late recurrence mandate that pediatricians and other primary care physicians consider the diagnosis of melanoma even in young patients with new skin lesions and that patients treated for melanoma be carefully followed for a lifetime.
Similar content being viewed by others
References
Boddie A, Smith JL, McBride C. Malignant melanoma in children and young adults.South Med J 1978;71:1074–8.
Melnik MK, Urdaneta LF, Al-Jurf S, Foucar E, Jochimsen PR, Soper RT. Malignant melanoma in childhood and adolescence.Am Surg 1986;52:142–7.
Rao BN, Hayes FA, Pratt CB, et al. Malignant melanoma in children: its management and prognosis.J Pediatr Surg 1990;25:198–205.
Lee JAH, Kongchaiyuaha S. Incidence and mortality from malignant melanoma by anatomical site.J Natl Cancer Inst 1971;47:253–63.
Kaplan EL, Meier P. Nonparametric estimation from incomplete observations.J Am Stat Assoc 1958;53:457–81.
Cox DR. Regression model and life tables.J R Stat Soc Br 1972;34:187–220.
Mahre E. Malignant melanomas in children.Arch Pathol Microbiol Scand 1963;59:184–93.
Reintgen DS, Vollmer RT, Seigler HF. Juvenile malignant melanoma.Surg Gynecol Obstet 1989;168:249–53.
Crowley NJ, Seigler HF. Relationship between disease-free interval and survival in patients with recurrent melanoma.Arch Surg 1992;127:1303–8.
Heller R, Becker J, Wasselle J, et al. Detection of submicroscopic lymph node metastases in patients with melanoma.Arch Surg 1991;126:1455–60.
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Davidoff, A.M., Cirrincione, C. & Seigler, H.F. Malignant melanoma in children. Annals of Surgical Oncology 1, 278–282 (1994). https://doi.org/10.1007/BF02303565
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/BF02303565